Top Markets
#1 MowCat MowCat +48.88%
#2 Audiera Audiera +27.37%
#3 Bermuda Shorts Bermuda Shorts +25.32%
#4 Velvet Velvet +23.57%
#5 aPriori aPriori +20.94%
#6 Quack AI Quack AI +19.92%
#7 Derive Derive +19.06%
#8 Biconomy Biconomy +18.82%
#9 SkyAI SkyAI +13.80%
#10 Geodnet Geodnet +11.33%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pharmaxis Ltd Pharmaxis Ltd

Pharmaxis Ltd

PXS
Classifica tra le azioni #35069
Pharmaxis Ltd, an Australian biopharmaceutical company founded in 1998 and... Pharmaxis Ltd, an Australian biopharmaceutical company founded in 1998 and based in Frenchs Forest, is globally focused on discovering, developing, and commercializing healthcare solutions for fibrotic and inflammatory conditions. Its operations are organized into two main divisions: the Mannitol Respiratory Business and New Drug Development. Currently, Pharmaxis markets Bronchitol, an inhaled dry powder used in the treatment of cystic fibrosis, and Aridol, a diagnostic tool that identifies hyper-responsive airways to aid in the diagnosis and management of asthma. The company's robust pipeline features several promising candidates. These include oral pan-lysyl oxidase (LOX) inhibitors targeting myelofibrosis and various other cancers, as well as topical pan-LOX inhibitors designed to address skin scarring caused by injuries, surgical procedures, and burns. Pharmaxis is also advancing selective Lysyl Oxidase Like Inhibitors (LOXL2) for a range of chronic fibrotic diseases, such as those affecting the kidneys, lungs, liver, and heart. Additionally, it is investigating semicarbazide-sensitive amine oxidase for potential use in neuro-inflammatory diseases. Further development includes Orbital, an innovative dry powder inhaler engineered to deliver high drug doses effectively to the lungs.
Prezzo delle azioni
$0.01285312
Ultima sincronizzazione: 2024-01-02
Capitalizzazione di mercato
$4.51M
Variazione (1 giorno)
-5.67%
Variazione (1 anno)
0.00%
Paese
AU
Scambia Pharmaxis Ltd (PXS)

Categoria

Healthcare
Storico dividendi per Pharmaxis Ltd (PXS)
Pharmaxis Ltd (simbolo azionario: PXS) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Pharmaxis Ltd (PXS) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00%
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
38.00%
IN